PACMAN trial protocol, Perioperative Administration of Corticotherapy on Morbidity and mortality After Non-cardiac major surgery: a randomised, multicentre, double-blind, superiority study - Aix-Marseille Université Access content directly
Journal Articles BMJ Open Year : 2019

PACMAN trial protocol, Perioperative Administration of Corticotherapy on Morbidity and mortality After Non-cardiac major surgery: a randomised, multicentre, double-blind, superiority study

Emmanuel Futier
Sigismond S. Lasocki
  • Function : Author
Olivier Huet
  • Function : Author
  • PersonId : 931798
Jean Etienne Bazin
  • Function : Author
Catherine Paugam Burtz
  • Function : Author
C Le Moal
  • Function : Author
G. Lebuffe
  • Function : Author
Guillaume Belliard
  • Function : Author
Thomas Rimmele
  • Function : Author
Vincent Piriou
  • Function : Author
  • PersonId : 761292
  • IdRef : 261570331
Nicolas Bruder
  • Function : Author
D. Mokart
  • Function : Author
Samir Jaber
Nolwen Chatel-Josse
  • Function : Author
Bertrand Rozec
  • Function : Author
Frederic Simonneau
  • Function : Author
F. Capron
  • Function : Author
Marc Beaussier
  • Function : Author
Benoit Plaud
  • Function : Author
J. Mantz
  • Function : Author
Bertrand Debaenne
  • Function : Author
B. Charbit
Helene Beloeil
  • Function : Author
Bertrand Dureuil
  • Function : Author
Serge Molliex
  • Function : Author
Julien Pottecher
Thomas Geeraerts

Abstract

Introduction Postoperative complications are major healthcare problems and are associated with a reduced short-term and long-term survival after surgery. An excessive postoperative inflammatory response participates to the development of postoperative infection and mortality. The aim of the Perioperative Administration of Corticotherapy on Morbidity and mortality After Non-cardiac surgery (PACMAN) study is to assess the effectiveness of perioperative administration of corticosteroid to reduce postoperative morbidity and mortality in patients undergoing major non-cardiac surgery. Methods and analysis The PACMAN is a multicentre, randomised, controlled, double-blind, superiority, two-arm trial of 1222 high-risk patients aged 50 years or older undergoing major non-cardiac surgery at 32 acute care hospital in France. Patients are randomly assigned to dexamethasone (0.2 mg/kg at the end of the surgical procedure and at day +1, n=611) or to placebo (n=611). The primary outcome is a composite of predefined 14-day major pulmonary complications and mortality. Secondary outcomes are surgical complications, infections, organ failures, critical care-free days, length of hospital stay and all-cause mortality at 28 days. Ethics and dissemination The PACMAN trial protocol has been approved by the ethics committee of Sud Mediterranée V, and will be carried out according to the Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. The PACMAN trial is a randomised controlled trial powered to investigate whether perioperative administration of corticosteroids in patients undergoing non-cardiac major surgery reduces postoperative complications. The results of this study will be disseminated through presentation at scientific conferences and publication in peer-reviewed journals.
Fichier principal
Vignette du fichier
bmjopen-2017-021262.pdf (496.09 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY NC - Attribution - NonCommercial

Dates and versions

hal-02509468 , version 1 (16-11-2023)

Licence

Attribution

Identifiers

Cite

Karim Asehnoune, Emmanuel Futier, Fanny Feuillet, Antoine Roquilly, Sigismond S. Lasocki, et al.. PACMAN trial protocol, Perioperative Administration of Corticotherapy on Morbidity and mortality After Non-cardiac major surgery: a randomised, multicentre, double-blind, superiority study. BMJ Open, 2019, 9 (3), pp.e021262. ⟨10.1136/bmjopen-2017-021262⟩. ⟨hal-02509468⟩
154 View
3 Download

Altmetric

Share

Gmail Facebook X LinkedIn More